Arnout Voet

Citée par

	Toutes	Depuis 2020
Citations	4641	2187
indice h	34	22
indice i10	63	44

500

250

125

375

200720082009201020112012201320142015201620172018201920202021202220232024202515 48 63 101 139 157 188 316 264 283 259 282 306 381 481 450 420 397 57

Accès public

Tout afficher

61 articles

16 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

zeger debyserKU LeuvenAdresse e-mail validée de med.kuleuven.be
Hiroki NoguchiPostdoctoral-fellow, Department of Chemistry, KU LeuvenAdresse e-mail validée de kuleuven.be
Frank ClaessensKU LeuvenAdresse e-mail validée de med.kuleuven.be
K.J. VerstrepenProfessor, KU Leuven and Group Leader, VIBAdresse e-mail validée de biw.vib-kuleuven.be
Patrick Van DijckKU LeuvenAdresse e-mail validée de kuleuven.be
Simoncini DavidUniversité de Toulouse I CapitoleAdresse e-mail validée de ut-capitole.fr
Wim DehaenVisiting professor of Chemistry in L.N. Gumilyov Eurasian UniversityAdresse e-mail validée de enu.kz
Stefan PrekovicCenter for Molecular Medicine, UMC UtrechtAdresse e-mail validée de umcutrecht.nl
Jelle HENDRIXAssociate ProfessorAdresse e-mail validée de uhasselt.be
Steven JoniauUrologist, University Hospitals LeuvenAdresse e-mail validée de uzleuven.be
Tom VenkenLaboratory of Translational Genetics, VIBAdresse e-mail validée de kuleuven.be
Nuno R. FariaProfessor, Imperial College London / University of São PauloAdresse e-mail validée de ic.ac.uk
Ricardo KhouriResearcher, Oswaldo Cruz Foundation (FIOCRUZ-Bahia) - Professor, UFBAAdresse e-mail validée de fiocruz.br
Philippe LemeyFull Professor, KU LeuvenAdresse e-mail validée de kuleuven.be
Andrea-Clemencia Pineda-PeñaSanofi: Global Clinical Development Vaccines; IHMT (Portugal); FIDIC (Colombia)Adresse e-mail validée de sanofi.com
Sofie MG SaerensApplication Manager in Wine Innovation, Chr HansenAdresse e-mail validée de chr-hansen.com
Chris MichielsKatholieke Universiteit Leuven, KU LeuvenAdresse e-mail validée de kuleuven.be
Christophe M. CourtinFull Professor, Centre Food & Microbial Tech., University of Leuven (KU LeuvenAdresse e-mail validée de biw.kuleuven.be
Jan AertsKU LeuvenAdresse e-mail validée de kuleuven.be
Bo ZhuAssociate professor at Shanghai Jiaotong UniversityAdresse e-mail validée de sjtu.edu.cn

Suivre

Arnout Voet

Hoofddocent (associate professor) KU Leuven

Adresse e-mail validée de kuleuven.be - Page d'accueil

laboratory of biomolecular modelling and design


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication F Christ, A Voet, A Marchand, S Nicolet, BA Desimmie, D Marchand, ... Nature chemical biology 6 (6), 442-448, 2010	561	2010
The Saccharomyces cerevisiae EHT1 and EEB1 genes encode novel enzymes with medium-chain fatty acid ethyl ester synthesis and hydrolysis capacity SM Saerens, KJ Verstrepen, SD Van Laere, DFRTJM Voet, AR Van v P J Biol Chem 281, 4446-4456, 2006	357	2006
FraC nanopores with adjustable diameter identify the mass of opposite-charge peptides with 44 dalton resolution G Huang, A Voet, G Maglia Nature communications 10 (1), 835, 2019	269	2019
Reconstruction of ancestral metabolic enzymes reveals molecular mechanisms underlying evolutionary innovation through gene duplication K Voordeckers, CA Brown, K Vanneste, E van der Zande, A Voet, S Maere, ... PLoS biology 10 (12), e1001446, 2012	246	2012
Fragment based drug design: from experimental to computational approaches A Kumar, A Voet, KYJ Zhang Current medicinal chemistry 19 (30), 5128-5147, 2012	201	2012
Pharmacophore modeling: advances, limitations, and current utility in drug discovery X Qing, X Yin Lee, J De Raeymaeker, J RH Tame, K YJ Zhang, ... Journal of Receptor, Ligand and Channel Research, 81-92, 2014	181	2014
Identification of the LEDGF/p75 binding site in HIV-1 integrase K Busschots, A Voet, M De Maeyer, JC Rain, S Emiliani, R Benarous, ... Journal of molecular biology 365 (5), 1480-1492, 2007	181	2007
Androgen receptor antagonists for prostate cancer therapy C Helsen, T Van den Broeck, A Voet, S Prekovic, H Van Poppel, S Joniau, ... Endocrine-related cancer 21 (4), T105-T118, 2014	174	2014
An integrated map of HIV genome-wide variation from a population perspective G Li, S Piampongsant, NR Faria, A Voet, AC Pineda-Peña, R Khouri, ... Retrovirology 12, 1-18, 2015	172	2015
Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV A Hombrouck, J De Rijck, J Hendrix, L Vandekerckhove, A Voet, ... PLoS pathogens 3 (3), e47, 2007	164	2007
Computational design of a self-assembling symmetrical β-propeller protein ARD Voet, H Noguchi, C Addy, D Simoncini, D Terada, S Unzai, SY Park, ... Proceedings of the National Academy of Sciences 111 (42), 15102-15107, 2014	136	2014
Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes JE Neggers, B Kwanten, T Dierckx, H Noguchi, A Voet, L Bral, K Minner, ... Nature Communications 9 (1), 502, 2018	118	2018
The effect of F877L and T878A mutations on androgen receptor response to enzalutamide S Prekovic, ME van Royen, ARD Voet, B Geverts, R Houtman, D Melchers, ... Molecular cancer therapeutics 15 (7), 1702-1712, 2016	116	2016
Guards of the great wall: bacterial lysozyme inhibitors L Callewaert, JM Van Herreweghe, L Vanderkelen, S Leysen, A Voet, ... Trends in microbiology 20 (10), 501-510, 2012	114	2012
Duplication of a promiscuous transcription factor drives the emergence of a new regulatory network K Pougach, A Voet, FA Kondrashov, K Voordeckers, JF Christiaens, ... Nature Communications 5 (1), 4868, 2014	77	2014
Functional conservation of HIV-1 Gag: implications for rational drug design G Li, J Verheyen, SY Rhee, A Voet, AM Vandamme, K Theys Retrovirology 10, 1-11, 2013	76	2013
The transcriptional co-activator LEDGF/p75 displays a dynamic scan-and-lock mechanism for chromatin tethering J Hendrix, R Gijsbers, J De Rijck, A Voet, J Hotta, M McNeely, J Hofkens, ... Nucleic acids research 39 (4), 1310-1325, 2011	72	2011
Repurposing the antidepressant sertraline as SHMT inhibitor to suppress serine/glycine synthesis–addicted breast tumor growth SL Geeraerts, KR Kampen, G Rinaldi, P Gupta, M Planque, N Louros, ... Molecular cancer therapeutics 20 (1), 50-63, 2021	62	2021
In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2 R Vancraenenbroeck, J De Raeymaecker, E Lobbestael, F Gao, ... Frontiers in molecular neuroscience 7, 51, 2014	62	2014
Biochemical and structural characterization of TLXI, the Triticum aestivum L. thaumatin-like xylanase inhibitor E Fierens, K Gebruers, ARD Voet, M De Maeyer, CM Courtin, JA Delcour Journal of Enzyme Inhibition and Medicinal Chemistry 24 (3), 646-654, 2009	61	2009

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs